| A viral-vectored multi-stage malaria vaccine regimen with protective and transmission-blocking efficacies Y Yusuf, T Yoshii, M Iyori, H Mizukami, S Fukumoto, DS Yamamoto, ... Frontiers in immunology 10, 2412, 2019 | 36 | 2019 |
| Adeno-associated virus as an effective malaria booster vaccine following adenovirus priming Y Yusuf, T Yoshii, M Iyori, K Yoshida, H Mizukami, S Fukumoto, ... Frontiers in Immunology 10, 730, 2019 | 30 | 2019 |
| Baculovirus-induced fast-acting innate immunity kills liver-stage Plasmodium TB Emran, M Iyori, Y Ono, F Amelia, Y Yusuf, A Islam, A Alam, M Tamura, ... The Journal of Immunology 201 (8), 2441-2451, 2018 | 25 | 2018 |
| Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model K Yoshida, M Iyori, AM Blagborough, AM Salman, P Dulal, KA Sala, ... Scientific reports 8 (1), 3896, 2018 | 22 | 2018 |
| Tinjauan Molekuler dan Epidemiologi Mutasi pada Virus SARS CoV-2 H Hartono, Y Yusuf Jurnal Bionature 22 (1), 43-49, 2021 | 18 | 2021 |
| Anopheline antiplatelet protein from mosquito saliva regulates blood feeding behavior A Islam, TB Emran, DS Yamamoto, M Iyori, F Amelia, Y Yusuf, ... Scientific reports 9 (1), 3129, 2019 | 18 | 2019 |
| Liver-Directed AAV8 Booster Vaccine Expressing Plasmodium falciparum Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model M Shahnaij, M Iyori, H Mizukami, M Kajino, I Yamagoshi, I Syafira, Y Yusuf, ... Frontiers in Immunology 12, 612910, 2021 | 15 | 2021 |
| Down‐selecting circumsporozoite protein‐based malaria vaccine: A comparison of malaria sporozoite challenge model F Amelia, M Iyori, TB Emran, DS Yamamoto, K Genshi, H Otsuka, ... Parasite Immunology 41 (5), e12624, 2019 | 6 | 2019 |
| Faktor Resiko Munculnya Plasmodium spp. Resisten Di Kecamatan Tapalang, Sulawesi Barat’ Y Yusuf Jurnal Bionature 15 (1), 41-44, 2014 | 6 | 2014 |
| Adeno-associated virus-based malaria booster vaccine following attenuated replication-competent vaccinia virus LC16m8Δ priming AA Hasyim, M Iyori, T Mizuno, Y Abe, I Yamagoshi, Y Yusuf, I Syafira, ... Parasitology International 92, 102652, 2023 | 5 | 2023 |
| Bukti munculnya malaria resisten artemisinin di Asia Y Yusuf Jurnal Bionature 14 (2), 129, 2014 | 5 | 2014 |
| Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort S Nurisyah, M Iyori, AA Hasyim, A Sakamoto, H Hashimoto, K Yamagata, ... Antibodies 12 (3), 60, 2023 | 4 | 2023 |
| Evaluasi rasio neutrofil limfosit (RNL) untuk diagnosis COVID-19 pada pasien di RS Tadjuddin Chalid, Makassar, Indonesia Y Yusuf, S Nurisyah, AA Hasyim, K Amru, AQ Kadir, AN Mutia J Bionature 22 (2), 79-85, 2021 | 4 | 2021 |
| Anti-Malarial Drug Resistance Y Yusuf Majalah Kedokteran Andalas 37 (1), 64-69, 2015 | 4 | 2015 |
| Infeksi Cacing Kremi Pada Penderita HIV Positif di Makassar Y Yusuf J. Bionature 16 (1), 54-57, 2013 | 3 | 2013 |
| The potential for zoonotic malaria transmission in five areas of Indonesia inhabited by non-human primates DH Permana, Hasmiwati, DA Suryandari, IE Rozi, L Syahrani, W Setiadi, ... Parasites & Vectors 16 (1), 267, 2023 | 2 | 2023 |
| Synergism of Anti-Malarial Effect of Carica papaya L. and Moringa oleifera Leaf Extracts in Mice Y Yusuf, RM Asri, R Go, MN Zuhair, KM Kaharuddin, MDK Parenden, ... Majalah Obat Tradisional 29 (1), 100-106, 2024 | 1* | 2024 |
| Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB. 1.5 in Indonesian Residents after Vaccination and Infection AA Hasyim, A Sakamoto, K Yamagata, KH Zainal, DDN Suparman, ... Antibodies 13 (3), 2024 | | 2024 |
| Adverse reactions following COVID-19 immunization in children of elementary school age Y Yusuf, AA Junaedi, NA Fadhilah, S Wahyuni BKM Public Health and Community Medicine, e9712-e9712, 2024 | | 2024 |
| Potential zoonotic malaria transmission in five areas inhabited by non-human primate in Indonesia DH Permana, H Hasmiwati, DA Suryandari, IE Rozi, L Syahrani, W Setiadi, ... | | 2023 |
